Sergey E. Parfenyev
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Oncology 10
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 4
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Nickolai A. Barlev (21 shared papers)Alexandra A. Daks (20 shared papers)Olga Fedorova (16 shared papers)Oleg Y. Shuvalov (18 shared papers)Aastha Singh (1 shared paper)Ritu Kulshreshtha (1 shared paper)Hans‐Uwe Simon (2 shared papers)Alexey Petukhov (5 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (7 papers)Biology Direct (3 papers)International Journal of Molecular Sciences (2 papers)Antioxidants (2 papers)Pharmaceuticals (1 paper)
- Partner nations
- RussiaKazakhstanSwitzerland
In The Last Decade
Sergey E. Parfenyev
24 papers receiving 299 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 49
- Drug Discovery 1
- Oncology 57
- Aging 4
- Reproductive Medicine 25
Countries citing papers authored by Sergey E. Parfenyev
This map shows the geographic impact of Sergey E. Parfenyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey E. Parfenyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey E. Parfenyev more than expected).
Fields of papers citing papers by Sergey E. Parfenyev
This network shows the impact of papers produced by Sergey E. Parfenyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey E. Parfenyev. The network helps show where Sergey E. Parfenyev may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergey E. Parfenyev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 61 | |
| 2 | 2022 | 38 | |
| 3 | 2017 | 29 | |
| 4 | 2023 | 21 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 17 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 14 | |
| 9 | 2016 | 13 | |
| 10 | 2020 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2025 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2016 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2024 | 3 |
About Sergey E. Parfenyev
Sergey E. Parfenyev is a scholar working on Oncology, Cancer Research, Molecular Biology, Reproductive Medicine and Neurology, having authored 28 papers that have together received 304 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer-related gene regulation (3 papers), Neuroblastoma Research and Treatments (2 papers), Heat shock proteins research (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (49 citations), Drug Discovery (1 citation), Oncology (57 citations), Aging (4 citations) and Reproductive Medicine (25 citations). Sergey E. Parfenyev has collaborated with scholars based in Russia, Kazakhstan and Switzerland. Frequent co-authors include Nickolai A. Barlev, Alexandra A. Daks, Olga Fedorova, Oleg Y. Shuvalov, Aastha Singh, Ritu Kulshreshtha, Hans‐Uwe Simon, Alexey Petukhov, Olga A. Efimova and Anna Andreyevna Pendina. Their work appears in journals such as Biochemical and Biophysical Research Communications, Biology Direct, International Journal of Molecular Sciences, Antioxidants and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.